Twist Bioscience Corp
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Leproust Emily M. (Chief Executive Officer) sold 41,570 shares of Twist Bioscience Corp (TWST) at an average of $151.98 ($150.56–$154.45, $6.32M total) across 5 trades on 2026-08-25 under a Rule 10b5-1 trading plan.
Cho Dennis (See Remarks) sold 1,598 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.22M total) on 2026-08-21.
Finn Patrick John (President and COO) sold 4,046 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.56M total) on 2026-08-21.
Over the past 7 days, alphai's AI scored 5 news stories mentioning TWST (Twist Bioscience Corp). Coverage has skewed bullish: 2 bullish, 2 neutral, and 1 bearish.
Recent TWST coverage spans insider activity, technology and earnings.
In the last 30 days, TWST insiders filed 30 SEC Form 4 transactions — no purchases and 30 sales ($41.2M). The most active reporter was Finn Patrick John, President and COO, with 9 filings. 57% of those filings were made under pre-arranged Rule 10b5-1 plans.
Large insider sell may signal confidence concerns, potentially pressuring the stock short term.
A modest insider sale by an officer, representing a small portion of holdings.
Insider sale by a top executive may signal reduced confidence, potentially pressuring the stock short-term.
Minor insider sell by a senior HR executive; unlikely to move price materially.
Minor insider sell may signal slight negative sentiment but size is modest.
alphai scores every news story that mentions TWST with an AI model for sentiment and relevance, and aggregates insider trades from Twist Bioscience Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Leproust Emily M. (Chief Executive Officer) sold 41,570 shares of Twist Bioscience Corp (TWST) at an average of $151.98 ($150.56–$154.45, $6.32M total) across 5 trades on 2026-08-25 under a Rule 10b5-1 trading plan.
1 min readCho Dennis (See Remarks) sold 1,598 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.22M total) on 2026-08-21.
1 min readFinn Patrick John (President and COO) sold 4,046 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.56M total) on 2026-08-21.
1 min readGreen Paula (SVP of Human Resources) sold 1,360 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.19M total) on 2026-08-21.
1 min readLaponis Adam (Chief Financial Officer) sold 1,965 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.27M total) on 2026-08-21.
1 min readLeproust Emily M. (Chief Executive Officer) sold 6,639 shares of Twist Bioscience Corp (TWST) at $139.07 ($0.92M total) on 2026-08-21.
1 min readWERNER ROBERT F. (Chief Accounting Officer) sold 1,523 shares of Twist Bioscience Corp (TWST) at an average of $140.02 ($139.07–$140.77, $0.21M total) across 2 trades over 2026-08-21 to 2026-08-24.
1 min readBond market volatility pressured stocks early in the week, with the Nasdaq dropping 2.1%. Biotech stocks surged: Moderna (MRNA) rose 177% after positive cancer trial results, and Twist Bioscience (TWST) gained 23% on AI-driven protein binder success. NVIDIA's earnings and the Jackson Hole symposium are upcoming market tests.
3 min readTwist Bioscience (TWST) stock rose 6.79% on strong investor optimism. The company reported Q3 revenue of $118.4M, up 23% YoY, with a 78% gross margin but negative EBIT margin and ROE. Guidance was raised to $456M-$457M for FY26, with Q4 adjusted EBITDA breakeven expected. The stock has seen strong technical performance, with resistance near $150 and support at $130-$135.
2 min readCho Dennis (See Remarks) sold 14,205 shares of Twist Bioscience Corp (TWST) at $129.75 ($1.84M total) on 2026-08-19 under a Rule 10b5-1 trading plan.
1 min read
